Aimia Pet Signs Second R&D Partnership Agreement with KGK Science
16 Nov 2023 //
GLOBENEWSWIRE
Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
11 Apr 2023 //
BUSINESSWIRE
KGK Science Announces Publication of Safety Studies on Paraxanthine
15 Feb 2023 //
BUSINESSWIRE
Wellbeing Subsidiary KGK Science Announces Successful Results of UP446
06 Dec 2022 //
BUSINESSWIRE
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
30 Nov 2022 //
BUSINESSWIRE
KGK Science Enters into Research Contract With Nova Mentis for Phase II A Trial
17 Nov 2022 //
BUSINESSWIRE
KGK Science Announces Delivery of CBD and THC Through the Skin of Volunteers
14 Nov 2022 //
BUSINESSWIRE
KGK Announces Psilocybin Microdose Formulation to be Submitted for Ph 2A Trial
06 Oct 2022 //
BUSINESSWIRE
KGK Science Opens New Clinical Research Center to Reimagine a Healthier Future
26 Sep 2022 //
BUSINESSWIRE